Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.41 |
| ▸ | CHEK2 | O96017 | 4/20 | 0.39 |
| ▸ | TNF | P01375 | 2/20 | 0.37 |
| ▸ | LITAF | Q99732 | 2/20 | 0.37 |
| ▸ | BACE1 | P56817 | 2/20 | 0.36 |
| ▸ | CTSD | P07339 | 1/20 | 0.36 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.36 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21890147 | 0.87 | PRMT5 (0.46) | BTKCHEK2TNFLITAFGPR119 | |
| SCHEMBL17121730 | 0.86 | BTK (0.43) | BTKCHEK2TNFLITAFBACE1 | |
| SCHEMBL19037547 | 0.85 | BTK (0.42) | BTKCHEK2TNFLITAFBACE1 | |
| SCHEMBL19046975 | 0.84 | BTK (0.41) | BTKCHEK2TNFLITAFBACE1 | |
| SCHEMBL21890766 | 0.83 | BTK (0.39) | BTKCHEK2TNFLITAFPIK3CA | |
| SCHEMBL18681340 | 0.82 | EGFR (0.55) | BTKCHEK2PDE3BPDE3A | |
| SCHEMBL16767773 | 0.80 | HSD11B1 (0.46) | BTKTNFLITAF | |
| SCHEMBL29531255 | 0.80 | HSD11B1 (0.46) | BTKTNFLITAF | |
| SCHEMBL16767775 | 0.80 | HSD11B1 (0.46) | BTKTNFLITAF | |
| SCHEMBL18681419 | 0.79 | BTK (0.39) | BTKCHEK2TNFLITAFBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017053537-A1 | BENZIMIDAZOLES FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES | CAPELLA THERAPEUTICS, INC. (US) | 2017-03-30 | — | — | WO | disclosed |